These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3001201

  • 1. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M, Sudo N, Furuya M, Arakawa O, Ikarashi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
    [Abstract] [Full Text] [Related]

  • 2. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H, Hirata T, Norisugi T, Furuno K, Ikehata N, Utsunomiya A, Kobayashi K, Negishi Y, Akiya K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [Abstract] [Full Text] [Related]

  • 3. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies].
    Inoue M, Fujita Y, Abe Y, Inoue Y, Ueda G, Tanizawa O, Minagawa J, Yamada T, Ohashi K, Ozaki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1799-805. PubMed ID: 4056529
    [Abstract] [Full Text] [Related]

  • 4. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y, Furuno K, Sano Y, Hirata T, Utsunomiya A, Nakajima H, Okabe K, Shimizu K, Akiya K, Fujiwara Y.
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [Abstract] [Full Text] [Related]

  • 5. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
    Inoue M, Inoue Y, Hiramatsu K, Tanaka Y, Yamasaki M, Ueda G, Minagawa J, Ozaki M, Yanagida T, Nishino H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
    [Abstract] [Full Text] [Related]

  • 6. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S, Nakanishi A, Noda T, Ando Y, Kamamoto Y, Moriyama I, Ichijo M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R, Caffier H, Horner G, Lang K, Filbry E.
    Cancer Detect Prev; 1985 Aug 20; 8(1-2):115-20. PubMed ID: 4064031
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T, Ohkuma Y, Yoshimura T, Sugimori H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun 20; 38(6):917-23. PubMed ID: 2426378
    [Abstract] [Full Text] [Related]

  • 9. [Tissue polypeptide antigen in gynecological cancer].
    Saitoh S, Nakanishi A, Noda T, Yoh S, Ando Y, Moriyama I, Ichijo M.
    Gan No Rinsho; 1985 Jan 20; 31(1):65-72. PubMed ID: 3981803
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y.
    Gan To Kagaku Ryoho; 1984 May 20; 11(5):1078-83. PubMed ID: 6721513
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H, Masuda T, Hattori A, Noguchi M, Ito Y, Nakanishi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep 20; 37(9):1883-92. PubMed ID: 2997349
    [Abstract] [Full Text] [Related]

  • 12. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
    Yamazaki K, Kumamoto Y, Tsukamoto T, Umehara T, Ohmura K.
    Hinyokika Kiyo; 1987 Oct 20; 33(10):1581-9. PubMed ID: 2451408
    [Abstract] [Full Text] [Related]

  • 13. Immuno-histological localization of tissue polypeptide antigen (TPA) in gynecological malignancies.
    Ikarashi T, Takeuchi S, Sudo N, Ueda M, Furuya M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct 20; 37(10):2117-20. PubMed ID: 3908587
    [Abstract] [Full Text] [Related]

  • 14. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E, Murae M, Koga R, Odawara Y, Nakabayashi Y, Yokoyama K, Nakata H, Totake T, Ochiai K, Yasuda M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov 20; 36(11):2121-8. PubMed ID: 6595320
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T, Inoue S, Tanaka N, Fujisaki S, Maeyama M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec 20; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract] [Full Text] [Related]

  • 16. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K, Yasui Y, Asai H, Hisaoka T, Mizuno K, Yagami Y.
    Gan No Rinsho; 1985 May 20; 31(5):544-8. PubMed ID: 3860666
    [Abstract] [Full Text] [Related]

  • 17. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan 20; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 18. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
    Haga E.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr 20; 28(4):595-604. PubMed ID: 2170727
    [Abstract] [Full Text] [Related]

  • 19. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A, Durán P, Lafuerza A, Bodi R, Solé LA, Rubio D, Ibarz L, De Torres JA, Domenech-Torné FM, Salvador L.
    Rev Esp Oncol; 1984 Apr 20; 31(3):409-14. PubMed ID: 6546169
    [Abstract] [Full Text] [Related]

  • 20. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A, Yakushiji M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):47-54. PubMed ID: 2157782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.